Delivery Order SPE2DB22D1103-SPE2DB25FTBF0

Award Date 10/31/24
Potential Completion Date 11/1/24
Potential Value $7.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a medication, with a ceiling value of $3,191.37. It is a firm fixed-price contract with an ultimate completion date of April 11, 2025. The contract is not set aside and was competitively awarded. AmerisourceBergen Drug Corp holds a larger Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. The contract has a ceiling value of $3,401.89 and an ultimate completion date of March 21, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a prescription medication. The contract has a ceiling value of $7,336.56 and a period of performance through April 18, 2025. It is a firm-fixed-price contract, and there is no set-aside designation, indicating open competition....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a prescription medication, with a ceiling value of $5,028.92 and a performance period through March 2025. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a prescription medication, to support federal healthcare programs. The contract has a ceiling value of $9,328.75 and a final completion date of November 5, 2024. The contract is a firm fixed-price delivery order, with no set-aside...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,834.31, is for the supply of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a prescription medication. The contract is a firm fixed-price delivery order with an ultimate completion date of April 29, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of WEGOVY 1.7 MG/0.75 ML PEN 0.75ML, a pharmaceutical product, to support federal healthcare programs. The contract has a ceiling value of $16,827.46 and a completion date of January 9, 2025. It is a firm fixed price contract and does not have a set-aside designation, indicating open...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. The contract has a ceiling value of $59,984.29 and an ultimate completion date of December 12, 2024. The contract is a firm fixed price delivery order, with no set-aside designations. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. The award has a ceiling value of $13,821.11 and a completion date of November 16, 2023. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a specialty medication, with a ceiling value of $2,892.42. The contract has an ultimate completion date of November 1, 2024 and is a firm fixed-price delivery order. AmerisourceBergen holds a separate $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
  • SPE2DB22D1103
    Indefinite Delivery Contract
  • SPE2DB22D1103-SPE2DB25FTBF0
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a prescription medication. The contract has a ceiling value of $7,715.92 and a completion date of November 1, 2024. It is a firm-fixed-price delivery order contract, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/20/25, 2:08 PM